CVS Offers $200 Wegovy Copay in Bid to Expand Coverage

CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey weight-loss shot, for more patients by allowing them to charge copays as high as $200.

It’s the latest move by pharmacy benefit managers, which negotiate drug prices on behalf of health plans, to deal with the surging demand for weight-loss medicines. The copay option would take effect starting next year.